RETATRUTIDE - 46 ads
Friday, August 29, 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Wednesday, August 20, 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Thursday, August 14, 2025
Quantity : 60mg*10via - Price : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 60mg*10via - Price : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 50mg*10via - Price : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 40mg*10via - Price : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 30mg*10via - Price : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 20mg*10via - Price : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 15mg*10via - Price : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 10mg*10via - Price : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 13, 2025
Quantity : 5mg*10vial - Price : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, August 12, 2025
Quantity : 15mg*10via - Price : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, August 12, 2025
Quantity : 10mg*10via - Price : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, August 12, 2025
Quantity : 5mg*10vial - Price : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Saturday, August 09, 2025
Quantity : 15mg*10via - Price : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Saturday, August 09, 2025
Quantity : 10mg*10via - Price : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday, August 06, 2025
Quantity : 5mg*10vial - Price : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, August 05, 2025
Quantity : 30mg*10via - Price : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, August 05, 2025
Quantity : 5mg*10vial - Price : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Friday, August 01, 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Thursday, July 31, 2025
Quantity : 20mg*10via - Price : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday, July 31, 2025
Quantity : 15mg*10via - Price : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday, July 31, 2025
Quantity : 10mg*10via - Price : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday, July 31, 2025
Quantity : 5mg*10vial - Price : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 60mg*10via - Price : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 50mg*10via - Price : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 40mg*10via - Price : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 30mg*10via - Price : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 20mg*10via - Price : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday, July 29, 2025
Quantity : 15mg*10via - Price : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Help on search
- The search engine doses not care about the case of your text. [ cats dogs ] will search pages talking of cats and dogs in the same page.
- The double quotes (") allow you to search an exact phrase, respecting all caracters including spaces.
- The MINUS (-) forbids a word, eg [ dogs -cats ] returns all pages with dogs but no cats inside the text. you can add a MINUS (-) before a sentence with double quotes ("), like -"white cats".



